Business Combinations - Additional Information (Details) - USD ($)	1 Months Ended		12 Months Ended
	Aug. 31, 2021	Apr. 30, 2017	Dec. 31, 2021	May 31, 2021
Business Acquisition [Line Items]
Goodwill			$ 50,897,000
Customer Relationships
Business Acquisition [Line Items]
Estimated amortization life of identified intangible assets assumed			12 years
Laboratory Information System Platform
Business Acquisition [Line Items]
Estimated amortization life of identified intangible assets assumed			5 years
Trade Name
Business Acquisition [Line Items]
Estimated amortization life of identified intangible assets assumed			10 years
FF Gene Biotech
Business Acquisition [Line Items]
Minority interest ownership percentage		28.00%
FF Gene Biotech
Business Acquisition [Line Items]
Business Combination,Fair value of noncontrolling interest		$ 8,100,000		$ 8,141,000
Percentage of effective investment		42.00%
Purchase price for effective investment		$ 19,000,000.0
Percentage of preexisting equity interest			30.00%
Gain recognized on preexisting investment			$ 3,700,000
Goodwill		23,100,000	23,100,000	23,082,000
Identified intangible assets assumed				$ 6,958,000
FF Gene Biotech | Royalty-Free Technology
Business Acquisition [Line Items]
Identified intangible assets assumed		$ 5,700,000
Estimated amortization life of identified intangible assets assumed		10 years
FF Gene Biotech | Customer Relationships
Business Acquisition [Line Items]
Identified intangible assets assumed		$ 1,200,000
Estimated amortization life of identified intangible assets assumed		5 years
Cytometry Specialists, Inc
Business Acquisition [Line Items]
Purchase price for effective investment	$ 53,359,000
Goodwill	27,484,000		27,500,000
Identified intangible assets assumed	$ 30,540,000
Percentage of acquisition of outstanding equity	100.00%
Undiscounted amounts required to pay under contingent consideration agreement, minimum	$ 0
Undiscounted amounts required to pay under contingent consideration agreement, maximum	10,000,000.0
Fair value of the contingent consideration recognized	10,000,000.0
Cytometry Specialists, Inc | Customer Relationships
Business Acquisition [Line Items]
Identified intangible assets assumed	$ 27,600,000
Estimated amortization life of identified intangible assets assumed	12 years
Cytometry Specialists, Inc | Laboratory Information System Platform
Business Acquisition [Line Items]
Identified intangible assets assumed	$ 1,900,000
Estimated amortization life of identified intangible assets assumed	5 years
Cytometry Specialists, Inc | Trade Name
Business Acquisition [Line Items]
Identified intangible assets assumed	$ 1,100,000
Estimated amortization life of identified intangible assets assumed	10 years
Discount for Lack of Marketability | FF Gene Biotech
Business Acquisition [Line Items]
Business combination, measurement input		0.28
Discount | FF Gene Biotech
Business Acquisition [Line Items]
Business combination, measurement input		0.35
Discount Owed to Market Participant Acquisition Premium | FF Gene Biotech
Business Acquisition [Line Items]
Business combination, measurement input		0.10
FF Gene Biotech
Business Acquisition [Line Items]
Equity interest to be made in joint venture		30.00%
Xilong Scientific
Business Acquisition [Line Items]
Equity interest to be made in joint venture				72.00%
General and Administrative
Business Acquisition [Line Items]
Acquisition related costs			$ 2,800,000